Search Results - "Sega, Emanuela I."

Refine Results
  1. 1

    Tumor detection using folate receptor-targeted imaging agents by Sega, Emanuela I., Low, Philip S.

    Published in Cancer and metastasis reviews (01-12-2008)
    “…Folate receptors are up-regulated on a variety of human cancers, including cancers of the breast, ovaries, endometrium, lungs, kidneys, colon, brain, and…”
    Get full text
    Journal Article
  2. 2

    Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation by Sega, Emanuela I, Leveson-Gower, Dennis B, Florek, Mareike, Schneidawind, Dominik, Luong, Richard H, Negrin, Robert S

    Published in PloS one (27-01-2014)
    “…Lag-3 has emerged as an important molecule in T cell biology. We investigated the role of Lag-3 in conventional T cell (Tcon) and regulatory T cell (Treg)…”
    Get full text
    Journal Article
  3. 3

    In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity by Nishimura, Ryosei, Baker, Jeanette, Beilhack, Andreas, Zeiser, Robert, Olson, Janelle A., Sega, Emanuela I., Karimi, Mobin, Negrin, Robert S.

    Published in Blood (15-09-2008)
    “…Cytokine-induced killer (CIK) cells are ex vivo–expanded T lymphocytes expressing both natural killer (NK)– and T-cell markers. CIK cells are cytotoxic against…”
    Get full text
    Journal Article
  4. 4

    Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells by Shin, Ho-Jin, Baker, Jeanette, Leveson-Gower, Dennis B., Smith, Aaron T., Sega, Emanuela I., Negrin, Robert S.

    Published in Blood (25-08-2011)
    “…Previous work has demonstrated that both rapamycin (RAPA) and IL-2 enhance CD4+CD25+Foxp3+ regulatory T-cell (Treg) proliferation and function in vitro. We…”
    Get full text
    Journal Article
  5. 5

    Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4–dependent mechanism by Leveson-Gower, Dennis B., Olson, Janelle A., Sega, Emanuela I., Luong, Richard H., Baker, Jeanette, Zeiser, Robert, Negrin, Robert S.

    Published in Blood (17-03-2011)
    “…CD4+ natural killer T (NKT) cells, along with CD4+CD25+ regulatory T cells (Tregs), are capable of controlling aberrant immune reactions. We explored the…”
    Get full text
    Journal Article
  6. 6

    Low-Dose Radiation Potentiates the Therapeutic Efficacy of Folate Receptor–Targeted Hapten Therapy by Sega, Emanuela I., Ph.D, Lu, Yingjuan, Ph.D, Ringor, Michael, Ph.D, Leamon, Christopher P., Ph.D, Low, Philip S., Ph.D

    “…Purpose Human cancers frequently overexpress a high-affinity cell-surface receptor for the vitamin folic acid. Highly immunogenic haptens can be targeted to…”
    Get full text
    Journal Article
  7. 7

    Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells by Leveson-Gower, Dennis B., Sega, Emanuela I., Kalesnikoff, Janet, Florek, Mareike, Pan, Yuqiong, Pierini, Antonio, Galli, Stephen J., Negrin, Robert S.

    Published in Blood (21-11-2013)
    “…To investigate the role of mast cells in hematopoietic cell transplantation, we assessed graft-versus-host disease (GVHD) in C57BL/6-KitW-sh/W-sh recipients,…”
    Get full text
    Journal Article
  8. 8

    Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models by Florek, Mareike, Sega, Emanuela I., Leveson-Gower, Dennis B., Baker, Jeanette, Müller, Antonia M.S., Schneidawind, Dominik, Meyer, Everett, Negrin, Robert S.

    Published in Blood (11-09-2014)
    “…Acute graft-versus-host disease (GVHD) is induced by alloreactivity of donor T cells toward host antigens presented on antigen-presenting cells (APCs)…”
    Get full text
    Journal Article
  9. 9
  10. 10

    IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease after Bone Marrow Transplantation by Colonna, Lucrezia, Florek, Mareike, Leveson-Gower, Dennis B, Sega, Emanuela I, Baker, Jeanette, Smith, Aaron T, Negrin, Robert S

    “…Abstract Regulatory T cell (Treg) immunotherapy is a promising strategy for the treatment of graft rejection responses and autoimmune disorders. Our and other…”
    Get full text
    Journal Article
  11. 11

    Role of Lymphocyte Activation Gene-3 by Sega, Emanuela I, Leveson-Gower, Dennis B, Florek, Mareike, Schneidawind, Dominik, Luong, Richard H, Negrin, Robert S

    Published in PloS one (27-01-2014)
    “…Lag-3 has emerged as an important molecule in T cell biology. We investigated the role of Lag-3 in conventional T cell (Tcon) and regulatory T cell (Treg)…”
    Get full text
    Journal Article
  12. 12

    The Inhibitory Receptor LAG-3 Is Not Essential for Regulatory T Cells Function but Influences Donor T Cell Potency in Acute Graft-Versus-Host-Disease by Sega, Emanuela I, Leveson-Gower, Dennis B, Florek, Mareike, Negrin, Robert S

    Published in Blood (18-11-2011)
    “…Abstract 1900 GVHD is a major complication of bone marrow transplantation (BMT) and results from donor T cells becoming activated and reacting to host…”
    Get full text
    Journal Article
  13. 13

    IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease Following Bone Marrow Transplantation by Colonna, Lucrezia, Florek, Mareike, Leveson-Gower, Dennis B, Sega, Emanuela I, Zeiser, Robert, Buess, Martin, Negrin, Robert S

    Published in Blood (18-11-2011)
    “…Abstract 4037 Allogeneic hematopoietic cell transplantation (HCT) is an effective treatment for many hematologic malignancies such as leukemia, lymphoma and…”
    Get full text
    Journal Article
  14. 14

    A Novel Model of Pre-Emptive ECP Treatment Shows Significant Reduction of Gvhd-Related Mortality In Mice by Florek, Mareike, Sega, Emanuela I, Mueller, Antonia MS, Leveson-Gower, Dennis B, Shizuru, Judith A, Negrin, Robert S

    Published in Blood (18-11-2011)
    “…Abstract 4025 Graft versus host disease (Gvhd) remains the major cause of morbidity and mortality after bone marrow transplantation (BMT). To prevent Gvhd the…”
    Get full text
    Journal Article
  15. 15

    Mast Cells Reduce Gvhd Severity In Allogeneic Transplantation by Reducing the Proliferation of Conventional T Cells by Leveson-Gower, Dennis B, Sega, Emanuela I, Kalesnikoff, Janet, Florek, Mareike, Galli, Stephen J, Negrin, Robert

    Published in Blood (19-11-2010)
    “…Abstract 243 Mast cells are important effector cells in many innate and adaptive immune responses, and can influence the function of several immune cells…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Gvhd Severity Is Regulated by the Adoptive Transfer Low Numbers of NKT Cells by a Mechanism Distinct From CD4+CD25+ Regulatory T Cells by Leveson-Gower, Dennis, Olson, Janelle, Sega, Emanuela I, Baker, Jeanette, Zeiser, Robert, Negrin, Robert

    Published in Blood (20-11-2009)
    “…Abstract 229 NKT cells, a subset of which are CD1d reactive, play an important immunoregulatory role in suppressing dysfunctional immune reactions, including…”
    Get full text
    Journal Article
  18. 18

    Rapamycin and IL-2 Prevents Lethal Acute Graft-Versus Host Disease by Expansion of Donor Type CD4+CD25+Foxp3+ Regulatory T Cells by Shin, Ho-Jin, Baker, Jeanette, Leveson-Gower, Dennis, Sega, Emanuela I, Negrin, Robert

    Published in Blood (20-11-2009)
    “…Abstract 1334 Poster Board I-356 Previous work has demonstrated that both rapamycin (RAPA) and IL-2 enhance CD4+CD25+Foxp3+ regulatory T cells (Treg)…”
    Get full text
    Journal Article
  19. 19

    Functional Comparison of Freshly Isolated and Ex-Vivo Expanded CD4+CD25+Foxp3+ Regulatory T Cells in Suppressing Murine Acute GvHD by Sega, Emanuela I, Leveson-Gower, Dennis, Nguyen, Vu H., Negrin, Robert

    Published in Blood (16-11-2008)
    “…Graft versus host disease (GVHD) is a major complication of hematopoietic stem cell transplantation resulting from donor T cell reactivity against host tissue…”
    Get full text
    Journal Article
  20. 20

    Biology Contribution: Low-Dose Radiation Potentiates the Therapeutic Efficacy of Folate Receptor-Targeted Hapten Therapy by Sega, Emanuela I, Lu, Yingjuan, Ringor, Michael, Leamon, Christopher P, Low, Philip S

    “…Purpose: Human cancers frequently overexpress a high-affinity cell-surface receptor for the vitamin folic acid. Highly immunogenic haptens can be targeted to…”
    Get full text
    Journal Article